The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Nanovis sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Nanovis Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Nanovis is a medical device company that develops and markets tissue regenerating implants for bone and soft tissues. The company offers products such as implant Nano surfaces, implantable scaffolds and cervical plate, lumbar PEEK interbody systems, pedicle screws, injectable biomaterials, nanostructure polymers and anaphase ceramics, among others. Its implant platform is used for fixation potential of a titanium scaffold; and designing and manufacturing for very high attachment strength of titanium to PEEK. Nanovis also develops implant Nano surfaces for dental, orthopedic, soft tissue repair, urogential, cardiovascular and neurosurgical implants, among others. The company advances nanostructured biomaterial and Nano surfaced implant programs along with strategic partners. It serves surgeons and hospital networks. Nanovis is headquartered in Columbia, Indiana, the US.

The key metrics of Nanovis related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Nanovis is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Nanovis.

For a detailed understanding of the performance of Nanovis, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.